168 related articles for article (PubMed ID: 8067274)
1. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Maes M; Meltzer HY; Bosmans E
Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY
J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381
[TBL] [Abstract][Full Text] [Related]
4. In vivo immunomodulatory effects of clozapine in schizophrenia.
Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
[TBL] [Abstract][Full Text] [Related]
5. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs.
Maes M; Bosmans E; Ranjan R; Vandoolaeghe E; Meltzer HY; De Ley M; Berghmans R; Stans G; Desnyder R
Schizophr Res; 1996 Jul; 21(1):39-50. PubMed ID: 8998275
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.
Müller N; Empl M; Riedel M; Schwarz M; Ackenheil M
Eur Arch Psychiatry Clin Neurosci; 1997; 247(6):308-13. PubMed ID: 9477010
[TBL] [Abstract][Full Text] [Related]
7. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
8. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
[TBL] [Abstract][Full Text] [Related]
9. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.
Lin A; Kenis G; Bignotti S; Tura GJ; De Jong R; Bosmans E; Pioli R; Altamura C; Scharpé S; Maes M
Schizophr Res; 1998 Jun; 32(1):9-15. PubMed ID: 9690329
[TBL] [Abstract][Full Text] [Related]
11. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
Rapaport MH; Lohr JB
Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
[TBL] [Abstract][Full Text] [Related]
12. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients.
Hinze-Selch D; Becker EW; Stein GM; Berg PA; Mullington J; Holsboer F; Pollmächer T
Neuropsychopharmacology; 1998 Aug; 19(2):114-22. PubMed ID: 9629565
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
[TBL] [Abstract][Full Text] [Related]
14. [Clozapine, cytokines, fever and sleep].
Hinze-Selch D; Mullington J; Pollmächer T
Wien Med Wochenschr; 1996; 146(13-14):311-3. PubMed ID: 9012164
[TBL] [Abstract][Full Text] [Related]
15. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
Sirota P; Meiman M; Herschko R; Bessler H
Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
[TBL] [Abstract][Full Text] [Related]
16. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
Maes M; Meltzer HY; Bosmans E
Neuropsychobiology; 1994; 30(2-3):57-60. PubMed ID: 7800164
[TBL] [Abstract][Full Text] [Related]
17. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
[TBL] [Abstract][Full Text] [Related]
18. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor.
Maes M; Bocchio Chiavetto L; Bignotti S; Battisa Tura GJ; Pioli R; Boin F; Kenis G; Bosmans E; de Jongh R; Altamura CA
Schizophr Res; 2002 Apr; 54(3):281-91. PubMed ID: 11950553
[TBL] [Abstract][Full Text] [Related]
19. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
Maes M; Meltzer HY; Buckley P; Bosmans E
Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
[TBL] [Abstract][Full Text] [Related]
20. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels.
Pollmächer T; Hinze-Selch D; Mullington J
J Clin Psychopharmacol; 1996 Oct; 16(5):403-9. PubMed ID: 8889915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]